8932		MBD2 may play an important role in modulating NSCLC patient survival and thus be useful for identifying NSCLC patients who would benefit most from aggressive therapy.	DOID:3908	NSCLC	18414412
8932		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	18676680
8932		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	18830263
8932		results indicate MBD2 is specifically & directly involved in transcriptional repression of hTERT in HeLa cells & breast, liver & neuroblastoma cancer cell lines; MBD2 seems to be a general repressor of hTERT in hTERT-methylated telomerase-positive cells	DOID:162	CANCER	18952593
8932		results indicate MBD2 is specifically & directly involved in transcriptional repression of hTERT in HeLa cells & breast, liver & neuroblastoma cancer cell lines; MBD2 seems to be a general repressor of hTERT in hTERT-methylated telomerase-positive cells	DOID:769	NEUROBLASTOMA	18952593
8932		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	19124506
8932		Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)	DOID:4	DISEASE	19170196
8932		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	19625176
8932		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	19690890
8932		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	19692168
8932		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	20453000
8932		In hilar cholangiocarcinoma, down-expression of miR-373 leads to increase of MBD2, which in turn suppresses the methylation-mediated gene such as RASSF1A.	DOID:4947	CHOLANGIOCARCINOMA	21086164
8932		In hilar cholangiocarcinoma, down-expression of miR-373 leads to increase of MBD2, which in turn suppresses the methylation-mediated gene such as RASSF1A.	DOID:4927	HILAR CHOLANGIOCARCINOMA	21086164
8932		miR-373 is a methylation-mediated gene and the implication of MBD2 in methylation-mediated suppression of miR-373 plays an important role in tumourigenesis and development in hilar cholangiocarcinoma.	DOID:4947	CHOLANGIOCARCINOMA	21165562
8932		miR-373 is a methylation-mediated gene and the implication of MBD2 in methylation-mediated suppression of miR-373 plays an important role in tumourigenesis and development in hilar cholangiocarcinoma.	DOID:4927	HILAR CHOLANGIOCARCINOMA	21165562
8932		Expression level of MBD2 is significantly lower in endometriotic lesions compared with disease-free controls.	DOID:4	DISEASE	21316665
8932		decreased expression in patients with primary immune thrombocytopenia	DOID:1588	THROMBOCYTOPENIA	21377502
8932		These results show a role for MBD2 in cancer progression and provide support for the prospect of targeting MBD2 therapeutically in aggressive breast cancers.	DOID:162	CANCER	21693597
8932		The association between MBD2 binding and transcriptional repression weakened as the distance between binding site and TSS increased, suggesting that MBD2 represses transcriptional initiation	DOID:14115	TSS	22048253
8932		A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility.	DOID:162	CANCER	22258532
8932		A two-stage association study identifies methyl-CpG-binding domain protein 2 gene polymorphisms as candidates for breast cancer susceptibility.	DOID:1612	BREAST CANCER	22258532
8932		MiR-373 behaves as a direct transcriptional target and negative regulator of MBD2 activity through a feedback loop of CpG island methylation in hilar cholangiocarcinoma	DOID:4947	CHOLANGIOCARCINOMA	22876037
8932		MiR-373 behaves as a direct transcriptional target and negative regulator of MBD2 activity through a feedback loop of CpG island methylation in hilar cholangiocarcinoma	DOID:4927	HILAR CHOLANGIOCARCINOMA	22876037
8932		In metastatic colorectal cancer cells, reduced levels of miR-221* and miR-224 increase levels of MBD2, thereby decreasing expression of the metastasis suppressor maspin.	DOID:162	CANCER	23770133
8932		In metastatic colorectal cancer cells, reduced levels of miR-221* and miR-224 increase levels of MBD2, thereby decreasing expression of the metastasis suppressor maspin.	DOID:9256	COLORECTAL CANCER	23770133
8934		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	20683486
8934		Direct DNA sequencing of the RAB7L1 and SLC41A1 genes within the PARK16 locus in 205 Chinese Parkinson's disease patients shows no significant difference with controls.	DOID:14330	PARKINSON'S DISEASE	21812739
8934		Direct DNA sequencing of the RAB7L1 and SLC41A1 genes within the PARK16 locus in 205 Chinese Parkinson's disease patients shows no significant difference with controls.	DOID:4	DISEASE	21812739
8934		This study demonstrated that specific SNP variations and haplotypes in the PARK16 locus are associated with reduced risk for parkinson disease in Ashkenazim.	DOID:4	DISEASE	22232350
8934		This study demonistrated that RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.	DOID:14330	PARKINSON'S DISEASE	23395371
8934		This study demonistrated that RAB7L1 interacts with LRRK2 to modify intraneuronal protein sorting and Parkinson's disease risk.	DOID:4	DISEASE	23395371
8935		Overexpression of SKAP2 is associated with the development of pancreatic ductal adenocarcinoma	DOID:299	ADENOCARCINOMA	17952125
8935		Overexpression of SKAP2 is associated with the development of pancreatic ductal adenocarcinoma	DOID:3008	DUCTAL ADENOCARCINOMA	17952125
8935		Overexpression of SKAP2 is associated with the development of pancreatic ductal adenocarcinoma	DOID:3498	PANCREATIC DUCTAL ADENOCARCINOMA	17952125
8935		Observational study of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	19913121
8935		Observational study and meta-analysis of gene-disease association. (HuGE Navigator)	DOID:4	DISEASE	20378605
8935		Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)	DOID:4	DISEASE	20628086
8935		results suggest that SKAP2 negatively regulates cell migration and tumor invasion in fibroblasts and glioblastoma cells by suppressing actin assembly induced by the WAVE2-cortactin complex	DOID:3068	GLIOBLASTOMA	23161539
8936		Results suggest that recruitment of factors by Wiskott-Aldrich Syndrome protein (WASP) and Scar1 stimulates cellular actin-based motility and actin nucleation with the Arp2/3 complex.	DOID:225	SYNDROME	12429845
8936		Results suggest that recruitment of factors by Wiskott-Aldrich Syndrome protein (WASP) and Scar1 stimulates cellular actin-based motility and actin nucleation with the Arp2/3 complex.	DOID:9169	WISKOTT-ALDRICH SYNDROME	12429845
8936		Dimerization act in hierarchical fashion, enabling WASP/WAVE proteins to integrate different classes of inputs to produce a wide range of cellular actin responses in Wiskoo Aldrich syndrome.	DOID:225	SYNDROME	18995840
8936		WAVE1 and p22phox expression in PBMCs increased and was associated with the disease course in children with acute lymphocytic leukemia (ALL).	DOID:1240	LEUKEMIA	19222940
8936		WAVE1 and p22phox expression in PBMCs increased and was associated with the disease course in children with acute lymphocytic leukemia (ALL).	DOID:9952	ACUTE LYMPHOCYTIC LEUKEMIA	19222940
8936		WAVE1 and p22phox expression in PBMCs increased and was associated with the disease course in children with acute lymphocytic leukemia (ALL).	DOID:4	DISEASE	19222940
8936		CIP4 is a new ArgBP2 interacting protein that modulates the ArgBP2 mediated control of WAVE1 phosphorylation and cancer cell migration.	DOID:162	CANCER	19631450
8936		WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia cells.	DOID:1240	LEUKEMIA	19890377
8936		Higher levels of WAVE1 in the bone marrow indicate an unfavorable prognosis in children with AML.	DOID:9119	AML	20426950
